These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6271798)

  • 1. Determination of ranitidine and its metabolites in human urine by reversed-phase ion-pair high-performance liquid chromatography.
    Carey PF; Martin LE; Owen PE
    J Chromatogr; 1981 Sep; 225(1):161-8. PubMed ID: 6271798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of high-performance liquid chromatography-mass spectrometry for the study of the metabolism of ranitidine in man.
    Martin LE; Oxford J; Tanner RJ
    J Chromatogr; 1982 Apr; 251(2):215-24. PubMed ID: 6284777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-pressure liquid chromatographic determination of ranitidine, a new H2-receptor antagonist, in plasma and urine.
    Mihaly GW; Drummer OH; Marshall A; Smallwood RA; Louis WJ
    J Pharm Sci; 1980 Oct; 69(10):1155-7. PubMed ID: 6252316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of the H2- receptor antagonist ranitidine in man.
    McNeil JJ; Mihaly GW; Anderson A; Marshall AW; Smallwood RA; Louis WJ
    Br J Clin Pharmacol; 1981 Sep; 12(3):411-5. PubMed ID: 6117305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method for the determination of ranitidine and its metabolites in urine by h.p.l.c. and its application to study the metabolism and pharmacokinetics of ranitidine in man.
    Carey PF; Martin LE; Owen P
    Biochem Soc Trans; 1981 Feb; 9(1):112. PubMed ID: 6111505
    [No Abstract]   [Full Text] [Related]  

  • 6. Ranitidine bioavailability and kinetics in normal male subjects.
    Garg DC; Weidler DJ; Eshelman FN
    Clin Pharmacol Ther; 1983 Apr; 33(4):445-52. PubMed ID: 6299642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of on-line high-performance liquid chromatography-mass spectrometry for the identification of ranitidine and its metabolites in urine.
    Martin LE; Oxford J; Tanner RJ
    Xenobiotica; 1981 Dec; 11(12):831-40. PubMed ID: 6281996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranitidine: single dose pharmacokinetics and absolute bioavailability in man.
    van Hecken AM; Tjandramaga TB; Mullie A; Verbesselt R; de Schepper PJ
    Br J Clin Pharmacol; 1982 Aug; 14(2):195-200. PubMed ID: 6125204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranitidine kinetics in normal subjects.
    Chau NP; Zech PY; Pozet N; Hadj-Aissa A
    Clin Pharmacol Ther; 1982 Jun; 31(6):770-4. PubMed ID: 6280919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualitative and quantitative analysis of ranitidine and its metabolites by high-performance liquid chromatography-mass spectrometry.
    Lant MS; Martin LE; Oxford J
    J Chromatogr; 1985 Apr; 323(1):143-52. PubMed ID: 4008551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and gastric secretory studies of ranitidine in man.
    Louis WJ; Mihaly GW; Hanson RG; Anderson A; McNeil JJ; Yeomans ND; Smallwood RA
    Scand J Gastroenterol Suppl; 1981 Jun; 69():11-7. PubMed ID: 6119773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of ranitidine in patients with renal failure.
    Garg DC; Baltodano N; Jallad NS; Perez G; Oster JR; Eshelman FN; Weidler DJ
    J Clin Pharmacol; 1986 Apr; 26(4):286-91. PubMed ID: 3700684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
    Stass H; Böttcher MF; Ochmann K
    Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cirrhosis and ageing on the elimination and bioavailability of ranitidine.
    Young CJ; Daneshmend TK; Roberts CJ
    Gut; 1982 Oct; 23(10):819-23. PubMed ID: 6126422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of ranitidine and its metabolites in human plasma and urine by high-performance liquid chromatography.
    Prueksaritanont T; Sittichai N; Prueksaritanont S; Vongsaroj R
    J Chromatogr; 1989 May; 490(1):175-85. PubMed ID: 2760148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of ranitidine.
    Roberts CJ
    Clin Pharmacokinet; 1984; 9(3):211-21. PubMed ID: 6329583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid analysis of ranitidine in biological fluids and determination of its erythrocyte partitioning.
    Mullersman G; Derendorf H
    J Chromatogr; 1986 Sep; 381(2):385-91. PubMed ID: 3760093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of ranitidine in patients undergoing haemofiltration.
    Gladziwa U; Krishna DR; Klotz U; Ittel TH; Schunkert H; Glöckner WM; Mann H
    Eur J Clin Pharmacol; 1988; 35(4):427-30. PubMed ID: 3197752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranitidine--a new H2-receptor antagonist.
    Woodings EP; Dixon GT; Harrison C; Carey P; Richards DA
    Gut; 1980 Mar; 21(3):187-91. PubMed ID: 6105117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of interaction of cimetidine and ranitidine with intravenous and oral midazolam.
    Greenblatt DJ; Locniskar A; Scavone JM; Blyden GT; Ochs HR; Harmatz JS; Shader RI
    Anesth Analg; 1986 Feb; 65(2):176-80. PubMed ID: 2935051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.